REGENATIVE LABS AND AAPC ANNOUNCE ICD 10 CODE LIST, SETTING THE FOUNDATION FOR SCIENTIFIC DISCUSSIONS REGARDING WHARTON'S JELLY
As part of an IRB-approved study, Regenative will utilize its data repository which, to Regenative's knowledge, is the nation's largest retrospective repository.
- As part of an IRB-approved study, Regenative will utilize its data repository which, to Regenative's knowledge, is the nation's largest retrospective repository.
- This data has enabled Regenative to identify over 180+ homologous use application sites for Wharton's Jelly.
- Through this repository, Regenative has been able to publish numerous papers, analyze and visualize the efficacy of Wharton's Jelly applications, and highlight outcomes-based practices.
- Seen below are examples of what Regenative has been able to do with the data collected, using language seen in AAPC's ICD-10 code list: